Review articleNew Diseases Derived or Associated with the Tight Junction
Introduction
Less than a decade ago, biomedicine started to discover a whole family of more than 50 “new” diseases related to the tight junction (TJ). We emphasize “new” because, of course, these diseases have been with us since the dawn of humankind, yet the novelty stems from the fact that they were not suspected to be due to failures of the TJ. With respect as to how we forecast that there would be more than 50 new diseases, the explanation is based on a fundamental tenet of evolutionary biology, affirming that natural selection does not incur in overdesign. This means that in spite of having some reserve capacity to deal with occasionally extreme circumstances, every organ or molecule is potentially vulnerable when its reserve capacity is exceeded. Accordingly, because today the TJ is known to consist of at least 50-odd different molecular species, each one with the capacity to fail, we may anticipate that there are, at least, an equal number of diseases waiting to be discovered. Unfortunately, a given protein can fail in more than one site, thereby multiplying the number of diseases. Some of these are already well documented. On this basis, the overall strategy of the present review consists of briefly describing the structure and function of the TJ, discusses what sort of diseases can be forecasted, mentions briefly the group of those diseases already known, and even refers to the pharmaceutical armamentarium that is being developed to fight them.
A single cell in the ocean exchanges nutrients and waste products with a constant reservoir that is not exhausted or polluted (Figure 1, upper left). When a cell is instead part of a multicellular organism, e.g., a human brain (Figure 1, upper center), it exchanges with an extremely narrow extracellular space (red) that would be quickly spoiled were it not for a circulatory system that transports substances to and from epithelial membranes in kidneys, lungs, intestine, etc. where the composition of the extracellular fluid is restored, due to an intense exchange with the external environment (1). All multicellular organisms, from Cnidaria up, have transporting epithelia, yet in mammals metabolism is so high that the exchange requires huge epithelial areas. To easily grasp its magnitude (Figure 1, lower left), we compare a few epithelial areas with the human silhouette. In fact, the crucial evolutionary step from unicellular to metazoan, and from these to higher organisms, was possible due to the emergence of transporting epithelia (2).
Epithelia can perform this role of exchangers due to two essential properties 2, 3, 4, 5, 6, 7. The first is their ability to establish TJs that seal the intercellular space and transform the layer of cells into an effective permeability barrier (Figure 1, below, center). The second is an apical/basolateral polarity: the apical domain of the plasma membrane facing the lumen of an intestine or the one in contact with the fluid inside a nephron (which represents in turn the external environment) has structural, chemical and physiological properties essentially different from those of the opposite pole of the cell (the basolateral domain). One of the major fields of modern biology is to learn how a given protein species, once synthesized, is delivered and incorporated into a TJ, the apical or the basolateral domains. This requires the identification of the molecular signals (most commonly a particular sequence of aminoacids) and the cell mechanisms that recognize them and address each molecular species towards the points where it would dwell and function (7).
The medical importance of epithelia is reflected by the fact that they are the basis of all gastrointestinal, kidney, lung, and other highly common diseases. This importance is compounded when we recall that some 85% of cancers in the adult originate in an epithelium and that, regardless of their causes, most deaths involve the final failure of an epithelium, such as those in the kidney, the liver, etc. This prompted a great effort to develop techniques to understand the cell and molecular physiology of epithelia 8, 9. This interest was multiplied for three additional reasons. In the first place, epithelia share a great deal of similarity, both at the cell and molecular level, with endothelia. Secondly, a metastasis prospers provided migrating cells can induce endothelial cells to form blood vessels at the site of arrival, otherwise the mass of the tumor cannot be nourished. Third, the intense exchange of substances between biological compartments alluded to above also takes place across endothelia. The importance of epithelia and endothelia is depicted in Figure 1 (below, right) representing the same illustration of Figure 1 (lower left) but in scale with the area of endothelia (yellow). The size of these tissues as compared with the human silhouette stresses the importance of understanding the cellular and molecular basis of the epithelial/endothelial phenotype.
Section snippets
Structure and Function of the TJ
Figure 2 represents molecular details of a TJ located at the outermost end of the intercellular space (Figure 1, below, center). The scope of this review does not justify digressing into molecular details or what the name of each protein species stands for. Nevertheless, it is worthwhile to point out that some are proteins that cross one [e.g., junctional adhesion molecule (JAM)] or four times the plasma membrane (e.g., claudins, occludins) 10, 11. Another group of junctional proteins does not
Foreseen Pathologies of the TJ
It is obvious that if a molecular defect causes a colon mucosa to have a TER of only 50 Ω·cm2, instead of having several thousand ohms, the organism will die swiftly of intoxication by products of its own intestinal flora penetrating through the leaky paracellular pathway. Conversely, if instead of having a TER of 5–10 Ω·cm2, a molecular imperfection in the proximal tubule of the kidney causes it to have several thousands ohms, the ensuing diuresis will kill us in a very short time. We can also
Diseases Involving TJs
After discussing the structural and physiological background of the TJ, it should not be a surprise that its pathologies conform a highly heterogeneous group of diseases, which at present are difficult to classify. Because a formal classification is premature, we will group them in disorders that resemble each other, those caused by mutations in proteins of the TJ, those associated with autoimmune reactions, cancers, and microorganisms, describing only paradigmatic diseases in each category.
Familial Renal Hypomagnesemia with Hypercalciuria and Nephrocalcinosis
Failure in this illness is clearly due to alteration of paracellin-1 (PCLN-1) gene, which results in the absence of the corresponding protein. In this autosomal recessive disease, patients have a profound renal Mg2+ and Ca2+ wasting, causing renal parenchymal calcification and renal failure that can only be cured through renal transplantation. PCLN-1, also known as claudin-16, is located in TJs of the thick ascending limb of Henle and forms an intercellular pore permitting paracellular passage
TJ Modifications in Immunity-related Diseases
As mentioned above, epithelia hamper the passage into the body of microorganisms, toxic substances and antigens 3, 6. When these barriers are damaged or when TJs are abnormally permeable, these antigens can penetrate the body and may cause an immune response 45, 46, 47, 48, 49, 50. Several antigen determinants are similar to host antigens and it is believed that, in vulnerable individuals, these might induce the generation of antibodies that cross-react with host antigens (51).
Towards a Pharmacology of the TJ
Today we have no specific agents to treat diseases of the TJ. Faced with an immunological disease produced by passage of a given allergenic substance through the paracellular route, all one can do is to prevent exposure to such substance. Because TJs have only been known for a century and a half, there are no traditional medicines to treat them, and these are likely to come from an intimate understanding of their structure and function. However, some specialists take advantage of natural
Looking for a TER-decreasing Factor
Although rotaviruses bind to intestinal receptors and cause diarrhea, they bind to receptors that are not exposed to the intestinal lumen, but hidden beyond the TJ in the basolateral domain of enterocytes. This situation, by itself, strongly suggests that in order to gain access to receptors, rotaviruses must have a way of opening the TJ. On this basis, Nava et al. 118, 121 explored whether the outer capsid protein VP4 of rotaviruses is capable of opening the paracellular space sealed by the
Looking for a TER-increasing Factor
As we have seen above, diseases like multiple sclerosis and diabetes are likely to be due to a defective sealing of the TJ that allows the passage of foreign peptides and that would challenge the immune system to produce antibodies against it. These antibodies may be addressed to epitopes also present in proteins of the brain, thyroid gland, pancreas, etc. The overall consequence is that a permissive TJ ends up causing an autoimmune disease. In keeping with this interpretation, these diseases
Conclusions
A few decades ago the TJ was assumed to be an obscure seal at the outermost end of the space between epithelial cells. Today, due to studies with transmission and freeze-fracture electron microscopy, as well as the use of epithelial cell lines cultured as monolayer that resemble natural epithelia, the TJ is known to be constituted by more than 50 different protein species whose specific role remains to be elucidated. Failure in these molecules results in a multitude of diseases ranging from
Acknowledgments
We thank Yadira Suarez for her technical and artistic drawings, and the kind and efficient help of Elizabeth del Oso and Jazmin De Lorenz. We gratefully acknowledge the economic support of CONACYT (National Research Council of Mexico).
References (138)
- et al.
Membrane targeting
Prog Biophys Mol Biol
(2003) - et al.
The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton
J Biol Chem
(1998) - et al.
Molecular characterization of the tight junction protein ZO-1 in MDCK cells
Exp Cell Res
(1999) - et al.
The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells
Exp Cell Res
(2004) - et al.
Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition
Dev Cell
(2005) - et al.
The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain
FEBS Lett
(1996) - et al.
Epithelial cell adhesion and the regulation of gene expression
Trends Cell Biol
(2003) - et al.
A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting
Am J Hum Genet
(2003) - et al.
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement
Am J Hum Genet
(2006) - et al.
Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29
Cell
(2001)